CD4 and synovial sarcoma: In general, these studies suggest a higher expression of PD-1 on CD4+ malignant cells in case of blood and skin of SS patients comparing to MF patients [174,175] and PD-1 has been proposed as a factor responsible for drug resistance in SS [176].